Evaluation of a Simple Pharmacokinetic Tool (myPKFiT™) to Guide Personalized Factor VIII Dosing in Patients With Hemophilia
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Hemophilia A
Related studies linked through entity extraction aliases.
Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study
- Status
- COMPLETED
- Phase
- N/A
Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients
- Status
- COMPLETED
- Phase
- PHASE4
Improved Factor VIII Inhibitor Evaluation
- Status
- WITHDRAWN
- Phase
- N/A
Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine Prophylaxis
- Status
- WITHDRAWN
- Phase
- N/A
BAX 826 Dose-Escalation Safety Study
- Status
- COMPLETED
- Phase
- PHASE1
GAS-Hem Feasibility Study
- Status
- COMPLETED
- Phase
- N/A
Ultrasonography in Hemophilic Joint Disease and Serum Markers
- Status
- COMPLETED
- Phase
- N/A
Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A
- Status
- COMPLETED
- Phase
- N/A
PK Driven Prophylaxis for Hemophilia A
- Status
- TERMINATED
- Phase
- NA
Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients
- Status
- UNKNOWN
- Phase
- N/A
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors
- Status
- COMPLETED
- Phase
- PHASE3
A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE3
BAX 855 PK-guided Dosing
- Status
- COMPLETED
- Phase
- PHASE3
Individualizing Hemophilia Prophylaxis Using Thromboelastography
- Status
- COMPLETED
- Phase
- NA
Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."
- Status
- COMPLETED
- Phase
- N/A
A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors
- Status
- COMPLETED
- Phase
- PHASE1
An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
National Study of a Pharmacokinetic-Focused Educational Package for Patients With Severe Haemophilia A
- Status
- COMPLETED
- Phase
- NA
Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
- Status
- COMPLETED
- Phase
- PHASE1